Personal tools
You are here: Home Recent publications Parkinson's

Parkinson's

Articles related to Parkinson's disease

 

1. Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Anti-Diabetes Drugs.

Binda C, Aldeco M, Geldenhuys WJ, Tortorici M, Mattevi A, Edmondson DE.

ACS Med Chem Lett. 2011 Oct 15;3(1):39-42.

PMID: 22282722 [PubMed]


2. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.

Anheim M, Elbaz A, Lesage S, Durr A, Condroyer C, Viallet F, Pollak P, Bonaïti B, Bonaïti-Pellié C, Brice A; On behalf of the French Parkinson Disease Genetic Group.

Neurology. 2012 Jan 25. [Epub ahead of print]

PMID: 22282650 [PubMed - as supplied by publisher]


3. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease.

Kostic VS, Agosta F, Pievani M, Stefanova E, Jecmenica-Lukic M, Scarale A, Spica V, Filippi M.

Neurology. 2012 Jan 25. [Epub ahead of print]

PMID: 22282641 [PubMed - as supplied by publisher]


4. Comment: Frontal lobes, executive dysfunction, gait and the fallacy of Pseudo-transitivity.

Montgomery EB Jr.

Neurology. 2012 Jan 25. [Epub ahead of print]

PMID: 22282640 [PubMed - as supplied by publisher]


5. Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor.

Iravani MM, Sadeghian M, Leung CC, Rose S, Jenner P.

Neurosci Lett. 2012 Jan 17. [Epub ahead of print]

PMID: 22281445 [PubMed - as supplied by publisher]


6. Molecular Interactions of Alzheimer's Aβ Protofilaments with Lipid Membranes.

Tofoleanu F, Buchete NV.

J Mol Biol. 2012 Jan 17. [Epub ahead of print]

PMID: 22281438 [PubMed - as supplied by publisher]


7. Microarray genomic profile of mitochondrial and oxidant response in manganese chloride treated PC12 cells.

Taka E, Mazzio E, Soliman KF, Renee Reams R.

Neurotoxicology. 2012 Jan 18. [Epub ahead of print]

PMID: 22281203 [PubMed - as supplied by publisher]


8. Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.

Ubhi K, Inglis C, Mante M, Patrick C, Adame A, Spencer B, Rockenstein E, May V, Winkler J, Masliah E.

Exp Neurol. 2012 Jan 16. [Epub ahead of print]

PMID: 22281106 [PubMed - as supplied by publisher]


9. Role of PINK1 Binding to the TOM Complex and Alternate Intracellular Membranes in Recruitment and Activation of the E3 Ligase Parkin.

Lazarou M, Jin SM, Kane LA, Youle RJ.

Dev Cell. 2012 Jan 24. [Epub ahead of print]

PMID: 22280891 [PubMed - as supplied by publisher]


10. Virtual reality as a tool for evaluation of repetitive rhythmic movements in the elderly and Parkinson's disease patients.

Arias P, Robles-García V, Sanmartín G, Flores J, Cudeiro J.

PLoS One. 2012;7(1):e30021. Epub 2012 Jan 18.

PMID: 22279559 [PubMed - in process] Free Article

Related citations
11. Molecular Chaperones in Parkinson's Disease - Present and Future.

Ebrahimi-Fakhari D, Wahlster L, McLean PJ.

J Parkinsons Dis. 2011 Nov;1(4):299-320.

PMID: 22279517 [PubMed]

Related citations
12. Assessment of cognitive fluctuation in dementia: a systematic review of the literature.

Lee DR, Taylor JP, Thomas AJ.

Int J Geriatr Psychiatry. 2012 Jan 25. doi: 10.1002/gps.2823. [Epub ahead of print]

PMID: 22278997 [PubMed - as supplied by publisher]

Related citations
13. Computation of the binding affinities of catechol-O-methyltransferase inhibitors: Multisubstate relative free energy calculations.

Nuno Palma P, João Bonifácio M, Isabel Loureiro A, Soares-da-Silva P.

J Comput Chem. 2012 Jan 25. doi: 10.1002/jcc.22926. [Epub ahead of print]

PMID: 22278964 [PubMed - as supplied by publisher]

Related citations
14. The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease.

Guella I, Soldà G, Cilia R, Pezzoli G, Asselta R, Duga S, Goldwurm S.

Mov Disord. 2012 Jan 25. doi: 10.1002/mds.24927. [Epub ahead of print] No abstract available.

PMID: 22278960 [PubMed - as supplied by publisher]

Related citations
15. Insilico study of the A(2A)R-D (2)R kinetics and interfacial contact surface for heteromerization.

Prakash A, Luthra PM.

Amino Acids. 2012 Jan 26. [Epub ahead of print]

PMID: 22278740 [PubMed - as supplied by publisher]

Related citations
16. Astragaloside IV prevents MPP(+)-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production.

Zhang ZG, Wu L, Wang JL, Yang JD, Zhang J, Zhang J, Li LH, Xia Y, Yao LB, Qin HZ, Gao GD.

Mol Cell Biochem. 2012 Jan 26. [Epub ahead of print]

PMID: 22278385 [PubMed - as supplied by publisher]

Related citations
17. [Psychosis in Parkinson's disease].

Rongve A, Auning E, Ehrt U, Arsland D.

Tidsskr Nor Laegeforen. 2012 Jan 24;132(2):155-8. Norwegian.

PMID: 22278271 [PubMed - in process] Free Article

Related citations
18. Couples' Coping in Prodromal Huntington Disease: A Mixed Methods Study.

Downing NR, Williams JK, Leserman AL, Paulsen JS.

J Genet Couns. 2012 Jan 26. [Epub ahead of print]

PMID: 22278219 [PubMed - as supplied by publisher]

Related citations
19. Malignant melanoma, breast cancer and other cancers in patients with parkinson disease.

Rugbjerg K, Friis S, Lassen CF, Ritz B, Olsen JH.

Int J Cancer. 2012 Jan 25. doi: 10.1002/ijc.27443. [Epub ahead of print]

PMID: 22278152 [PubMed - as supplied by publisher]

Related citations
20. Co-occurrence of parkinsonism and dementia in clinical practice : Relevant differential diagnoses.

Liepelt-Scarfone I, Jamour M, Maetzler W.

Z Gerontol Geriatr. 2012 Jan;45(1):23-33.

PMID: 22278003 [PubMed - as supplied by publisher]

Related citations
Document Actions